Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Global Blood-Grouping Reagents Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.
The latest market analysis predicts significant growth in the global blood-grouping reagents market, with an expected increase of USD 520.68 million over the 2023-2028 period. The growth trajectory is anticipated to showcase a robust CAGR of 8.13%, propelled by the escalating prevalence of chronic diseases, a surge in blood donation activities, and an upsurge in the number of hospitals and blood banks implementing these reagents.
Segmentation Insights and Regional Outlook
The market segmentation highlights the end-user applications ranging from hospitals and blood banks to clinical laboratories and academic as well as research institutes. The distinct techniques analyzed in this market include PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing techniques, and serology methods.
Geographically, the market landscape is dissected into key regions such as North America, Europe, Asia, and the Rest of the World. Each region’s market potential is carefully assessed, reflecting the global reach and relevance of blood-grouping reagents.
Technological Innovations Spur Market Demand
Market growth is further spurred by technological advancements in diagnostic devices. Innovations such as multiplexing assays and the integration of automation and high-throughput platforms in blood grouping are setting novel standards, thereby fuelling the expansion of the market. In this evolving landscape, market participants are expected to encounter substantial opportunities, influenced by forthcoming trends and industry-driven challenges.
Comprehensive Market Evaluation by Industry Leaders
The blood-grouping reagents market is a competitive arena, characterized by the presence of distinguished industry players. These entities are recognized for their contributions to market growth and are instrumental in shaping the market dynamics. The report’s in-depth evaluation provides stakeholders with crucial insights, preparing them to competently navigate market nuances and capitalize on growth prospects.
The blood-grouping reagents market is segmented as below:
By End-user
- Hospitals and blood banks
- Clinical laboratories
- Academic and research institutes
By Technique
- PCR-based and microarray techniques
- Assay-based techniques
- Massively parallel sequencing techniques
- Serology
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
Companies Profiled:
- AliveDX
- Arena Bio Scien
- ARKRAY Inc.
- Atlas Medical GmbH
- BAG Health Care GmbH
- Bio Rad Laboratories Inc.
- Calibre Scientific Inc.
- Danaher Corp.
- DIAGAST SAS
- Grifols SA
- Merck KGaA
- Novacyt SA
- QuidelOrtho Corp.
- Rapid Labs Ltd.
- Thermo Fisher Scientific Inc.
- Torax Biosciences Ltd.
- Tulip Diagnostics Pvt. Ltd.
- Fortress Diagnostics
- Paragon Care Ltd.
- VitroScient
For more information about this report visit https://www.researchandmarkets.com/r/7ppg20
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
